The Chairman's Report gives us guidance on the progress of the Janssen collaboration;
"Successful delivery on this project should trigger a significant licence fee payment in early 2014," page 3.
So what is early 2014? The Director's Report provides a tighter timeline;
"In February 2014 Phylogica hopes to achieve a major technical milestone for the Janssen collaboration that can potentially trigger a significant licence payment," page 18.
So it would appear that early 2014 is in fact February 2014. A licencing deal with Janssen would be transformational. Not only would it "create opportunities to further expand the relationship with Janssen" but it would also provide compelling validation for the technology. There is much to play for despite the lean year of deal flow.
- Forums
- ASX - By Stock
- PYC
- janssen
PYC
pyc therapeutics limited
Add to My Watchlist
3.03%
!
$1.28

janssen
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.28 |
Change
-0.040(3.03%) |
Mkt cap ! $746.5M |
Open | High | Low | Value | Volume |
$1.32 | $1.35 | $1.28 | $764.7K | 579.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 4000 | $1.28 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.30 | 40248 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 4000 | 1.275 |
1 | 13987 | 1.265 |
2 | 16060 | 1.260 |
1 | 12000 | 1.255 |
2 | 2800 | 1.250 |
Price($) | Vol. | No. |
---|---|---|
1.300 | 40248 | 3 |
1.330 | 5000 | 1 |
1.345 | 53113 | 2 |
1.350 | 22000 | 2 |
1.360 | 5958 | 1 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online